Start SIP in ARVEE
Start SIPPerformance
- Low
- ₹153
- High
- ₹161
- 52 Week Low
- ₹117
- 52 Week High
- ₹315
- Open Price₹159
- Previous Close₹160
- Volume563
Investment Returns
- Over 1 Month -12.56%
- Over 3 Month -27.34%
- Over 6 Month -15.35%
- Over 1 Year -4.48%
Smart Investing Starts Here Start SIP with Arvee Laboratories (India) for Steady Growth!
Arvee Laboratories (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 75.4
- PEG Ratio
- 1.9
- Market Cap Cr
- 172
- P/B Ratio
- 5.9
- Average True Range
- 8.56
- EPS
- 2.07
- Dividend Yield
- 0
- MACD Signal
- -4.67
- RSI
- 41.96
- MFI
- 47.07
Arvee Laboratories (India) Financials
Arvee Laboratories (India) Technicals
EMA & SMA
Current Price
₹155.75
-4.5
(-2.81%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹165.98
- 50 Day
- ₹171.44
- 100 Day
- ₹174.71
- 200 Day
- ₹173.38
Resistance and Support
159.95
- R3 167.85
- R2 165.12
- R1 162.68
- S1 157.51
- S2 154.78
- S3 152.34
Arvee Laboratories (India) Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-14 | Quarterly Results & Others | To consider other business matters. issue in the ratio of 1:1 of Rs. 10/-. |
2024-08-13 | Quarterly Results | |
2024-02-13 | Quarterly Results | (Revised) issue in the ratio of 1:1 of Rs. 10/-. |
2023-11-07 | Quarterly Results | |
2023-08-11 | Quarterly Results |
Arvee Laboratories (India) F&O
About Arvee Laboratories (India)
- NSE Symbol
- ARVEE
- BSE Symbol
- Managing Director
- Mr. Shalin Sudhakarbhai Patel
- ISIN
- INE006Z01016
Similar Stocks to Arvee Laboratories (India)
Arvee Laboratories (India) FAQs
Arvee Laboratories (India) share price is ₹155 As on 22 January, 2025 | 12:15
The Market Cap of Arvee Laboratories (India) is ₹171.6 Cr As on 22 January, 2025 | 12:15
The P/E ratio of Arvee Laboratories (India) is 75.4 As on 22 January, 2025 | 12:15
The PB ratio of Arvee Laboratories (India) is 5.9 As on 22 January, 2025 | 12:15
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.